Pages that link to "Q59544957"

The following pages link to Evidence for alcohol anti-craving properties of memantine (Q59544957):

Displaying 38 items.

• Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date (Q27004490) (← links)
• Pharmacodynamics of memantine: an update (Q30490604) (← links)
• Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data (Q30580986) (← links)
• Effects of a novel uncompetitive NMDA receptor antagonist, MRZ 2/579 on ethanol self-administration and ethanol withdrawal seizures in the rat. (Q31925767) (← links)
• In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists. (Q33856557) (← links)
• Recent animal models of alcoholism. (Q34152146) (← links)
• N-methyl-D-aspartate receptor antagonism has differential effects on alcohol craving and drinking in heavy drinkers (Q35091293) (← links)
• Glutamatergic mechanisms in addiction (Q35124983) (← links)
• N-methyl-D-aspartate glutamate receptors and alcoholism: reward, dependence, treatment, and vulnerability (Q35153745) (← links)
• Sleep disturbances, psychiatric disorders, and psychotropic drugs (Q35236639) (← links)
• Role of altered structure and function of NMDA receptors in development of alcohol dependence (Q36499757) (← links)
• mTOR activation is required for the anti-alcohol effect of ketamine, but not memantine, in alcohol-preferring rats (Q36823796) (← links)
• Treatment of alcohol dependence in patients with co-morbid major depressive disorder--predictors for the outcomes with memantine and escitalopram medication (Q36942553) (← links)
• Effects of topiramate and other anti-glutamatergic drugs on the acute intoxicating actions of ethanol in mice: modulation by genetic strain and stress (Q37159920) (← links)
• Interactions of a Dopamine D1 Receptor Agonist with Glutamate NMDA Receptor Antagonists on the Volitional Consumption of Ethanol by the mHEP Rat. (Q37277407) (← links)
• Selective increases of AMPA, NMDA, and kainate receptor subunit mRNAs in the hippocampus and orbitofrontal cortex but not in prefrontal cortex of human alcoholics (Q37526327) (← links)
• Pharmacologic dissociation between impulsivity and alcohol drinking in high alcohol preferring mice (Q37668767) (← links)
• Medications development for the treatment of alcohol use disorder: insights into the predictive value of animal and human laboratory models (Q38718932) (← links)
• The anti-craving compound acamprosate acts as a weak NMDA-receptor antagonist, but modulates NMDA-receptor subunit expression similar to memantine and MK-801. (Q40804149) (← links)
• Discriminative stimulus effects of ethanol: neuropharmacological characterization (Q43070510) (← links)
• Blockade by the cannabinoid CB(1) receptor antagonist, SR 141716, of alcohol deprivation effect in alcohol-preferring rats (Q44014660) (← links)
• Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats (Q44394325) (← links)
• Neurobehavioral effects of alcohol in AMPA receptor subunit (GluR1) deficient mice (Q44519053) (← links)
• Role of Fyn tyrosine kinase in ethanol consumption by mice (Q44579513) (← links)
• Acute effects of memantine in combination with alcohol in moderate drinkers. (Q44609217) (← links)
• mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior (Q44736089) (← links)
• Long-lasting increase of alcohol relapse by the cannabinoid receptor agonist WIN 55,212-2 during alcohol deprivation. (Q45072847) (← links)
• The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat. (Q45236957) (← links)
• The effect of 12-week open-label memantine treatment on cognitive function improvement in patients with alcohol-related dementia (Q46697169) (← links)
• Memantine enhances the inhibitory effects of naltrexone on ethanol consumption (Q46703142) (← links)
• Effects of the NMDA receptor antagonist memantine on the expression and development of acute opiate dependence as assessed by withdrawal-potentiated startle and hyperalgesia (Q46890768) (← links)
• Glutamate Receptors within the Mesolimbic Dopamine System Mediate Alcohol Relapse Behavior. (Q50553045) (← links)
• Behavioral effects of aminoadamantane class NMDA receptor antagonists on schedule-induced alcohol and self-administration of water in mice (Q52012754) (← links)
• Disruption of operant oral self-administration of ethanol, sucrose, and saccharin by the AMPA/kainate antagonist, NBQX, but not the AMPA antagonist, GYKI 52466. (Q52171841) (← links)
• Memantine does not substantially affect brain stimulation reward: comparison with MK-801. (Q52173563) (← links)
• Memantine fails to facilitate partial cigarette deprivation in smokers – no role of Memantine in the treatment of nicotine dependency? (Q57780603) (← links)
• Effects of chronic alcohol consumption on the expression of different NR1 splice variants in the brain of AA and ANA lines of rats (Q73101797) (← links)
• Ethanol-reinforced behaviour in the rat: effects of uncompetitive NMDA receptor antagonist, memantine (Q77354701) (← links)